Lloyd Minor

CIK: 0002038687

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CAI

Caris Life Sciences, Inc.

Director

BIIB

BIOGEN INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CAI
Caris Life Sciences, Inc.
Aug 14, 2026
Award(A)
Direct
13.2K shares-
BIIB
BIOGEN INC.
Aug 4, 2026
Sale(S)
Direct
593 shares at avg. $200.96$119K
BIIB
BIOGEN INC.
Aug 3, 2026
Sale(S)
Direct
593 shares at avg. $203.34$121K
BIIB
BIOGEN INC.
Jun 9, 2026
Award(A)
Direct
1.5K shares-
CAI
Caris Life Sciences, Inc.
Feb 26, 2026
Award(A)
Direct
2.5K shares at avg. $20.06$50K
BIIB
BIOGEN INC.
Jun 17, 2025
Award(A)
Direct
2.4K shares-

		Type	Shares	Price		Ownership
Aug 14, 2026	CAI Caris Life Sciences, Inc.	Award(A)	13,192	-	$0	Direct
Aug 4, 2026	BIIB BIOGEN INC.	Sale(S)	593	$200.96	$119,169	Direct
Aug 3, 2026	BIIB BIOGEN INC.	Sale(S)	593	$203.34	$120,581	Direct
Jun 9, 2026	BIIB BIOGEN INC.	Award(A)	1,505	-	$0	Direct
Feb 26, 2026	CAI Caris Life Sciences, Inc.	Award(A)	2,492	$20.06	$49,990	Direct
Jun 17, 2025	BIIB BIOGEN INC.	Award(A)	2,370	-	-	Direct

1-6 of 6 transactions

About Minor Lloyd

Minor Lloyd (SEC CIK 0002038687) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI) and Director of BIOGEN INC. (BIIB).

Signal8 holds 7 ownership filings by Minor Lloyd (2 Form 3, 5 Form 4), filed between Oct 7, 2024 and Aug 14, 2026. Those filings report 6 transactions, from Jun 17, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Minor Lloyd's filings is in CAMBRIDGE, MA.

Recent filings by Minor Lloyd

Aug 14, 2026: Grant or award of CAI shares (Form 4, code A).
Aug 4, 2026: Open-market sale of BIIB shares (Form 4, code S).
Aug 3, 2026: Open-market sale of BIIB shares (Form 4, code S).
Jun 9, 2026: Grant or award of BIIB shares (Form 4, code A).
Feb 26, 2026: Grant or award of CAI shares (Form 4, code A).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes